Fintech PR
Top 5 questions to cover on cybercrime when looking at equity investing
All companies, regardless of size or industry, are vulnerable to cyber threats like phishing scams, ransomware attacks, and data breaches, according to Prism Global Group.
LONDON, Oct. 16, 2023 /PRNewswire/ — In today’s digital age, the threat of cybercrime looms large over businesses and individuals alike. The need for robust cybersecurity solutions has never been more critical as the world becomes increasingly interconnected. To stay ahead of the curve, organisations must take proactive steps to protect their digital assets from malicious attacks.
Most companies that investors are looking at are proactive and vigilant in addressing cybersecurity threats. Cybersecurity must be prioritised, as it serves as an intelligent investment, safeguarding the firm’s assets and reputation and ensuring long-term success.
Alev Dover, CEO of Prism Global Group, stated: “Cybersecurity is a significant concern for businesses of all sizes and industries. Threats like data breaches, ransomware, and scams can lead to financial losses, reputation damage, and legal responsibility. Protecting your business against these threats is crucial.
Prism has identified five effective strategies to enhance cybersecurity. When investors look at the company that they wish to invest in, these controls are a helpful list to check against:
1. Is the firm regularly testing their defences and ensuring they are prepared for any possible situation?
As technology advances, the potential for security breaches increases. With each new addition to a company’s systems, such as users, applications, devices, and acquisitions, the complexity of cybersecurity grows. Therefore, organisations need a regular process that identifies security gaps, vulnerabilities, and loopholes before they lead to major incidents.
2. How is the firm implementing identity and access management systems?
To keep daily operations running smoothly and protect sensitive information from unauthorised access, it’s crucial to have a system that allows for appropriate data access to prevent internal breaches. Data breaches are caused by insider threats like misusing privileged access, weak or stolen passwords, unpatched applications, malware, social engineering, and physical attacks. To protect against both external and internal threats, it’s crucial that the firm has a robust data security program in place to safeguard sensitive data.
3. Does the firm conduct regular cybersecurity awareness training?
Equipping employees with cybersecurity knowledge and best practices is essential to defend against phishing and social engineering attacks. Providing education on identifying these types of attacks and understanding what information should not be shared is crucial. Every individual within an organisation can play a significant role in maintaining cybersecurity.
4. What Network Monitoring measures are in place?
Effective network security monitoring services safeguard organisations against potential security threats. By providing constant surveillance, these services enable prompt identification and response to suspicious activities, thus minimising the risk of a significant breach. To ensure maximum protection, it is crucial to have trained professionals monitoring the business network for any unusual behaviour that may indicate a potential attack.
5. Who at the firm is responsible for device discovery & continuous policy enforcement?
To improve network security, teams can identify and evaluate endpoints for vulnerabilities. If any issues are found, steps can be taken to address them, such as separating insecure endpoints from the rest of the network, and the problem can be quickly discovered and fixed if a resource violates established security policies. Newly installed devices that match a particular device profile with an active policy are also automatically protected.
Dover concluded: ‘From reading industry research and talking with our investment networks we can conclude that significant cybersecurity breaches cause material, short term declines in stock price and market share. These analyses are based on reviewing publicly disclosed breaches and tracking stock price post-breach.
Our company’s equity investment platform and products are highly secure in terms of cybersecurity. This assurance enables us to instil confidence for all our clients and the financial markets when they make long-term investment decisions. We maintain strict controls that undergo regular reviews to ensure the utmost security.
About Prism Global Group
Prism Global Group is an innovator of a new equity orientated financial infrastructure.
The company was established in Sydney and has expanded its international footprint under CEO Alev Dover. PRISM moved its global HQ to London in 2022.
This disclaimer is for Prism Global Group Plc (Reg No: 14476793), Prism Global Group Ltd (ACN 630 730 415), Prism Global (UKEUR) Ltd (Reg No 13579812), Prism Operations Australia Pty Ltd (ACN650 476 378) and Prism Securities Australia Ltd (ACN 650 488 136) and any other associated entities referred to collectively as ‘Prism’.
Prism Operations Australia Pty Ltd is a Corporate Authorised Representative (authorised representative number: 1292289) of Sanlam Private Wealth Pty Ltd (“Sanlam”) which is the holder of an Australian Financial Services Licence (AFS Licence No. 337927).
Prism Global (UKEUR) Ltd (FRN: 999737) is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority (FRN: 550103) as an arranger for investments only. For avoidance of doubt, Prism Global (UKEUR) Limited does not manufacture or issue investments, and only arranges for deals in investments issued by Prism Group companies.
View original content:https://www.prnewswire.co.uk/news-releases/top-5-questions-to-cover-on-cybercrime-when-looking-at-equity-investing-301957763.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News5 days ago
B Lab UK research reveals UK public back change to company law to put people, the planet and profit on more equal footing
-
Latest News5 days ago
Unleash a Wave of Opportunities this May with Bybit
-
Latest News4 days ago
Bankart migrates payment processing to Diebold Nixdorf’s Vynamic Transaction Middleware
-
Latest News3 days ago
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
-
Latest News4 days ago
Cayman Enterprise City Publishes Socio-Economic Impact Assessment by Economist and Leading Advisor on the Caribbean, Marla Dukharan
-
Latest News5 days ago
What Does Nuvei’s Go-Private Deal Portend for FinTechs?
-
Latest News4 days ago
SANY Heavy Industry Reports 2023 Earnings: Overseas Revenue Soars to 60% of Core Business Amid Market Pressures, Signaling Strong Global Expansion
-
Latest News4 days ago
Call for Projects: Over $3 Million Investment for International Audiovisual Contents at TCCF PITCHING 2024